Search | Page 16 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels

    Journal Title:  Biol Blood Marrow Transplant Primary Author:  ... in a fludarabine -based conditioning regimen for bone marrow transplantation from unrelated donors in patients with severe ...

    Research Article last updated 07/30/2012 - 1:47pm.

  2. Reduced intensity conditioning, combined transplantation of haploidentical hematopoietic stem cells and mesenchymal stem cells in patients with severe aplastic anemia

    ... colony-stimulating factor (G-CSF)-primed bone marrow and G-CSF-mobilized peripheral blood stem cells of haploidentical ... (500 mg/m2·d)+anti-human thymocyte IgG. Transplant recipients also received cyclosporin A, mycophenolatemofetil, and ...

    Research Article last updated 04/09/2014 - 9:16am.

  3. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myeloid leukemia following aplastic anemia

    Journal Title:  Biol Blood Marrow Transplant Primary Author:  ... 4.4 to 26.7 years), patients underwent HSCT with bone marrow (n = 6) or peripheral blood stem cell (n = 11) grafts from ...

    Research Article last updated 01/07/2014 - 12:37pm.

  4. Multicenter study evaluating the impact of hypomethylating agents as bridging therapy to hematopoietic stem cell transplantation in myelodysplastic syndromes

    ... However, for patients with a high blast count (>5 % of bone marrow at the time of diagnosis), pre-transplant HMA therapy had a NRM ...

    Research Article last updated 04/16/2014 - 12:24pm.

  5. HLA-Matched Sibling Transplantation for Severe Aplastic Anemia: Impact of HLA DR15 Antigen Status on Engraftment, Graft-versus-Host Disease, and Overall Survival.

    Journal Title:  Biol Blood Marrow Transplant Primary Author:  ... (SAA). We studied 1204 recipients of HLA-matched sibling bone marrow transplantation for SAA to determine whether HLA DR15 status ...

    Research Article last updated 06/15/2012 - 2:55pm.

  6. A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes.

    Journal Title:  Bone Marrow Transplant Primary Author:  ...

    Research Article last updated 06/28/2013 - 1:30pm.

  7. Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network.

    Journal Title:  Biol Blood Marrow Transplant Primary Author:  ... the basic science, immunosuppressive therapy (IST), and bone marrow transplantation (BMT) of SAA and propose initiatives to ...

    Research Article last updated 10/11/2011 - 5:58pm.

  8. SAA Patient Dominique Hughes Contributes to NIH Research

    ... to the local hematologist who did my very first bone marrow biopsy . When the results came back, he said that he had never seen a ...

    Patient Chronicle last updated 03/21/2017 - 11:32am.

  9. Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia

    Journal Title:  Bone Marrow Transplant Primary Author:  ...

    Research Article last updated 09/04/2014 - 11:22am.

  10. Specific abnormalities versus number of abnormalities and cytogenetic scoring systems for outcome prediction after allogeneic hematopoietic SCT for myelodysplastic syndromes

    Journal Title:  Bone Marrow Transplant Primary Author:  ...

    Research Article last updated 05/22/2014 - 9:03am.